Pulmatrix Inc (PULM)
6.12
+0.01
(+0.16%)
USD |
NASDAQ |
Nov 22, 16:00
6.145
+0.02
(+0.41%)
After-Hours: 20:00
Pulmatrix Total Assets (Quarterly): 11.51M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 11.51M |
June 30, 2024 | 15.78M |
March 31, 2024 | 30.39M |
December 31, 2023 | 33.96M |
September 30, 2023 | 36.77M |
June 30, 2023 | 31.39M |
March 31, 2023 | 36.06M |
December 31, 2022 | 40.95M |
September 30, 2022 | 46.45M |
June 30, 2022 | 49.40M |
March 31, 2022 | 54.30M |
December 31, 2021 | 58.82M |
September 30, 2021 | 55.75M |
June 30, 2021 | 65.43M |
March 31, 2021 | 69.85M |
December 31, 2020 | 38.10M |
September 30, 2020 | 42.96M |
June 30, 2020 | 35.07M |
March 31, 2020 | 30.82M |
December 31, 2019 | 36.10M |
September 30, 2019 | 32.92M |
June 30, 2019 | 37.05M |
March 31, 2019 | 13.99M |
December 31, 2018 | 14.72M |
Date | Value |
---|---|
September 30, 2018 | 16.28M |
June 30, 2018 | 20.58M |
March 31, 2018 | 13.72M |
December 31, 2017 | 15.98M |
September 30, 2017 | 19.32M |
June 30, 2017 | 23.52M |
March 31, 2017 | 22.79M |
December 31, 2016 | 16.66M |
September 30, 2016 | 25.48M |
June 30, 2016 | 28.82M |
March 31, 2016 | 40.22M |
December 31, 2015 | 44.87M |
September 30, 2015 | 47.66M |
June 30, 2015 | 50.31M |
March 31, 2015 | 10.68M |
December 31, 2014 | 11.87M |
September 30, 2014 | 13.27M |
June 30, 2014 | 14.65M |
March 31, 2014 | 15.58M |
December 31, 2013 | 1.425M |
September 30, 2013 | 1.123M |
June 30, 2013 | 0.712M |
March 31, 2013 | 0.148M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.51M
Minimum
Sep 2024
69.85M
Maximum
Mar 2021
40.99M
Average
37.43M
Median
Total Assets (Quarterly) Benchmarks
Entero Therapeutics Inc | 85.82M |
Johnson & Johnson | 178.29B |
Savara Inc | 238.82M |
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.59M |
Shareholders Equity (Quarterly) | 10.92M |
Current Ratio | 19.40 |